CSTONE PHARMACEUTICALS
8Patents
8Active
8Granted
47Portfolio score
Filing activity: Sep 21, 2016 → Jul 3, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10745389B2 | HDAC6 selective inhibitors, preparation method therefor, and application thereof | Chemistry; Metallurgy | 3 | Active |
| US11661452B2 | Anti-lag-3 antibody polypeptide | Physics | 1 | Active |
| US11414487B2 | Monoclonal antibodies to programmed death 1 (PD-1) | Chemistry; Metallurgy | 0 | Active |
| US10676474B2 | 1,6-naphthyridine derivatives as CDK4/6 inhibitor | Human Necessities | 0 | Active |
| US10829483B2 | Thiophene, manufacturing method thereof, and pharmaceutical application of same | Chemistry; Metallurgy | 0 | Active |
| US11021486B2 | Coumarin-like cyclic compound as MEK inhibitor and use thereof | Human Necessities | 0 | Active |
| US11312715B2 | Fused ring derivative as A2A receptor inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11345682B2 | Polymorph of HDAC6-selective inhibitor and application thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.